Silverleafe Capital Partners LLC Buys New Position in Tempus AI, Inc. (NASDAQ:TEM)

Silverleafe Capital Partners LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the fourth quarter, HoldingsChannel reports. The fund bought 15,782 shares of the company’s stock, valued at approximately $533,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of TEM. Franklin Resources Inc. lifted its position in Tempus AI by 1.0% during the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock worth $45,920,000 after acquiring an additional 8,387 shares during the period. Tidal Investments LLC purchased a new position in Tempus AI in the 3rd quarter valued at $7,633,000. Teachers Retirement System of The State of Kentucky increased its stake in Tempus AI by 6.3% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company’s stock valued at $7,160,000 after buying an additional 7,500 shares during the period. Geode Capital Management LLC raised its position in Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after buying an additional 539 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of Tempus AI in the 3rd quarter worth $502,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on TEM. Wolfe Research began coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price target for the company. Bank of America upped their price objective on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Loop Capital raised their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Finally, Guggenheim assumed coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

Tempus AI Trading Up 7.2 %

Shares of NASDAQ:TEM traded up $2.74 during mid-day trading on Monday, hitting $40.99. 2,965,889 shares of the company traded hands, compared to its average volume of 3,596,364. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49. The firm’s 50 day simple moving average is $48.93 and its 200 day simple moving average is $46.86. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Insider Activity

In other news, major shareholder Bradley A. Keywell sold 395,800 shares of the business’s stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the sale, the insider now owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. The trade was a 2.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Ryan Fukushima sold 120,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.51, for a total value of $5,101,200.00. Following the sale, the chief operating officer now owns 1,007,207 shares in the company, valued at $42,816,369.57. The trade was a 10.65 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 845,041 shares of company stock worth $35,125,473 over the last 90 days.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.